Published by mark itwired
Posted on September 13, 2021
ESOMAR-certified consulting firm Future Market Insights’ projects the global sleep apnea diagnostic systems market valuation to reach US$ 5.4 Bn over the forecast period of 2021 and 2031.
Growing demand for advanced polysomnography (PSG) devices within sleep centers & clinics and hospitals is accelerating sleep apnea diagnostic systems sales across the globe.
Demand for sleep apnea diagnostic systems is rising extensively in emerging economies as there is a large pool of undiagnosed and untreated sleep apnea patients.
Increasing application within sleep centers & clinics and at homecare settings for in-lab testing is expected to spur the sales during the assessment period.
As per the FMI’s analysis, due to the outbreak of COVID-19, the global sleep apnea diagnostic systems market registered spike in demand as the number of patients with depression and mental health issues spurred during 2020-2021.
Increasing funding by governments and initiatives undertaken to create awareness about sleep disorders have encouraged manufacturers to increase the research & development activities. This also has encouraged the development of advanced PSG devices and wearable sleep apnea diagnostic systems.
“Ever expanding pool of undiagnosed sleep apnea patients, especially across developing economies such as India, China, and Brazil, will generate remunerative growth opportunities for the sleep apnea diagnostic systems market players over the coming years,” says the FMI analyst.
Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-777
Koninklijke Philips N.V., Becton, Dickinson, and Company, Braeden Medical Corporation, Advanced Brain Monitoring Inc., SOMNO medics GmbH, ResMed Inc., BMC Medical Co. Ltd., Natus Medical Incorporated, MGC Diagnostic Corporation, and Cleveland Medical Devices Inc. among others are some prominent players operating in the Sleep apnea diagnostic systems market.
As per the FMI’s analysis, Koninklijke Philips N.V., and ResMed Inc. are identified as leading players in the sleep apnea diagnostic systems market. These manufacturers are focusing on product innovation and new launches to maintain their leading position.
Collaborations with hospitals and sleep centers & clinics is the core strategy to strengthen their distribution networks. Key players are also focusing on other strategies such as mergers and product introductions to increase their sales.
Other regional and local players also account for considerable market share in the global sleep apnea diagnostic systems market, opines Future Market Insights.
In its latest report, FMI provides an incisive coverage on the global sleep apnea diagnostic systems market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (polysomnography (PSG) devices, sleep apnea screening devices, and actigraphy monitoring devices), end-user (home care settings, hospitals, and sleep centers & clinics), and across major regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)
Speak to Analyst, Questions Related To Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-777
1.1. Market Outlook
1.2. Analysis and Recommendations
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3.1. Macro-Economic Factors
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity Analysis
3.1.4. Trends
4.1. U.S FDA Regulations for Medical Devices
4.2. Europe Regulations for Medical Devices
4.3. Japan Regulations for Medical Devices
5.1. Historical Market Value (US$ Mn) Analysis, 2016 – 2020
5.2. Current and Future Market Value (US$ Mn) Projections, 2021 – 2031
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
5.2.3. Market Value Comparison
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2016 – 2020
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2021 – 2031
6.3.1. Polysomnography (PSG) Devices
6.3.1.1. Ambulatory PSG Monitoring Devices
6.3.1.2. Clinical PSG Monitoring Devices
6.3.2. Sleep Apnea Screening Devices
6.3.2.1. Nasal Flow Sensors
6.3.2.2. Peripheral Capillary Oxygen Saturation (SPO2)
6.3.3. Actigraphy Monitoring Devices
6.4. Market Attractiveness Analysis By Product Type
The post Sleep Apnea Diagnostic Systems Market is Projected to grow at 5.7% CAGR by 2031 first appeared on Market Research Blog.
ESOMAR-certified consulting firm Future Market Insights’ projects the global sleep apnea diagnostic systems market valuation to reach US$ 5.4 Bn over the forecast period of 2021 and 2031.
Growing demand for advanced polysomnography (PSG) devices within sleep centers & clinics and hospitals is accelerating sleep apnea diagnostic systems sales across the globe.
Demand for sleep apnea diagnostic systems is rising extensively in emerging economies as there is a large pool of undiagnosed and untreated sleep apnea patients.
Increasing application within sleep centers & clinics and at homecare settings for in-lab testing is expected to spur the sales during the assessment period.
As per the FMI’s analysis, due to the outbreak of COVID-19, the global sleep apnea diagnostic systems market registered spike in demand as the number of patients with depression and mental health issues spurred during 2020-2021.
Increasing funding by governments and initiatives undertaken to create awareness about sleep disorders have encouraged manufacturers to increase the research & development activities. This also has encouraged the development of advanced PSG devices and wearable sleep apnea diagnostic systems.
“Ever expanding pool of undiagnosed sleep apnea patients, especially across developing economies such as India, China, and Brazil, will generate remunerative growth opportunities for the sleep apnea diagnostic systems market players over the coming years,” says the FMI analyst.
Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-777
Koninklijke Philips N.V., Becton, Dickinson, and Company, Braeden Medical Corporation, Advanced Brain Monitoring Inc., SOMNO medics GmbH, ResMed Inc., BMC Medical Co. Ltd., Natus Medical Incorporated, MGC Diagnostic Corporation, and Cleveland Medical Devices Inc. among others are some prominent players operating in the Sleep apnea diagnostic systems market.
As per the FMI’s analysis, Koninklijke Philips N.V., and ResMed Inc. are identified as leading players in the sleep apnea diagnostic systems market. These manufacturers are focusing on product innovation and new launches to maintain their leading position.
Collaborations with hospitals and sleep centers & clinics is the core strategy to strengthen their distribution networks. Key players are also focusing on other strategies such as mergers and product introductions to increase their sales.
Other regional and local players also account for considerable market share in the global sleep apnea diagnostic systems market, opines Future Market Insights.
In its latest report, FMI provides an incisive coverage on the global sleep apnea diagnostic systems market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (polysomnography (PSG) devices, sleep apnea screening devices, and actigraphy monitoring devices), end-user (home care settings, hospitals, and sleep centers & clinics), and across major regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)
Speak to Analyst, Questions Related To Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-777
1.1. Market Outlook
1.2. Analysis and Recommendations
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3.1. Macro-Economic Factors
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity Analysis
3.1.4. Trends
4.1. U.S FDA Regulations for Medical Devices
4.2. Europe Regulations for Medical Devices
4.3. Japan Regulations for Medical Devices
5.1. Historical Market Value (US$ Mn) Analysis, 2016 – 2020
5.2. Current and Future Market Value (US$ Mn) Projections, 2021 – 2031
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
5.2.3. Market Value Comparison
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2016 – 2020
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2021 – 2031
6.3.1. Polysomnography (PSG) Devices
6.3.1.1. Ambulatory PSG Monitoring Devices
6.3.1.2. Clinical PSG Monitoring Devices
6.3.2. Sleep Apnea Screening Devices
6.3.2.1. Nasal Flow Sensors
6.3.2.2. Peripheral Capillary Oxygen Saturation (SPO2)
6.3.3. Actigraphy Monitoring Devices
6.4. Market Attractiveness Analysis By Product Type
The post Sleep Apnea Diagnostic Systems Market is Projected to grow at 5.7% CAGR by 2031 first appeared on Market Research Blog.
Explore more articles in the Research Reports category
